Astrotech Corp (ASTC) - Q1 2026 (Ended Sept 30, 2025) Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. Astrotech Corporation (ASTC) is a Delaware corporation developing and commercializing mass spectrometry (MS) and gas chromatography (GC) technology for security, environmental, and industrial applications. The company operates through wholly-owned subsidiaries including 1st Detect (security), AgLAB (agriculture/cannabis), BreathTech (health), Pro-Control (industrial), and EN-SCAN (environmental). The company is classified as a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q1 2026 (Sept 30, 2025) | Q1 2025 (Sept 30, 2024) |
|---|---|---|
| Revenue | $297,000 | $34,000 |
| Gross Profit | $188,000 | $9,000 |
| Gross Margin | 63.3% | 26.5% |
| Operating Expenses | $3,724,000 | $3,637,000 |
| Net Loss | $(3,465,000) | $(3,278,000) |
| Net Loss Per Share (Basic/Diluted) | $(2.07) | $(2.01) |
| Cash and Cash Equivalents | $2,646,000 | $6,518,000 (End of Q1 2025) |
| Short-Term Investments | $11,290,000 | $0 (End of Q1 2025) |
| Total Assets | $23,240,000 | $26,989,000 (Prior Quarter) |
| Working Capital | $16,334,000 | $19,524,000 (Prior Quarter) |
Material Changes vs. Prior Period
- Revenue Surge: Revenue increased by $263,000 (773%) compared to the prior year quarter. This was primarily driven by $234,000 in grant revenue from the completion of milestones in Phases I and II of a government contract.
- Margin Expansion: Gross margin improved significantly from 26.5% to 63.3%, attributed to a shift in revenue mix toward higher-margin grant revenue and consumables.
- Operating Expenses: Total operating expenses increased slightly by $87,000 (2.4%). Selling, general, and administrative (SG&A) expenses rose $92,000 due to property taxes and hiring, while R&D expenses remained relatively flat, decreasing by $5,000.
- Liquidity Shift: Cash and cash equivalents decreased by $454,000 during the quarter. However, the company liquidated $3.966 million in short-term investments to fund operations, resulting in a net cash burn of $3.936 million from operating activities.
- Lease Obligations: The company entered a new 89-month lease for the "Metric Facility" in Austin, Texas, commencing July 1, 2025, with a total contractual base rent obligation of approximately $3.0 million.
Guidance, Outlook, and Risks
- Product Milestones:
- 1st Detect: The TRACER 1000 ETD received TSA approval for the Air Cargo Security Technology List (Stage II testing). The company secured a $429,000 purchase order for six units from a TSA-approved contractor in April 2025 and deployed the first Narcotic Trace Detector (NTD) in Vietnam in June 2025.
- AgLAB: Field trials for the AgLAB 1000-D2 demonstrated yield improvements of 15% to 30% in cannabis distillation processes.
- BreathTech: The pilot study with Cleveland Clinic concluded in February 2025. Management has decided to deploy capital to other subsidiaries rather than pursue further BreathTech commercialization at this time.
- Outlook: Management expects the effective tax rate for the full fiscal year 2026 to remain at 0% due to a full valuation allowance on net deferred tax assets. No specific financial guidance for future quarters was provided in this filing.
- Risks and Contingencies:
- Customer Concentration: Three customers accounted for substantially all revenue ($297,000) in Q1 2026. In Q1 2025, one customer accounted for all revenue.
- Liquidity: The company continues to incur net losses and relies on cash reserves and short-term investments to fund operations. Continued losses may require additional financing.
- Regulatory: Success depends on government funding, TSA certification milestones, and evolving regulations in the cannabis and environmental sectors.
Investor Verification Checklist
- Grant Sustainability: Verify the duration and renewal likelihood of the government grants that drove the majority of Q1 revenue.
- TSA Certification Progress: Monitor the status of the TRACER 1000 Stage II field trials and the timeline for full "qualified" list status, which is critical for large-scale U.S. government sales.
- Cash Burn Rate: Assess the runway provided by current cash ($2.6M) and short-term investments ($11.3M) against the quarterly operating cash burn of approximately $3.9M.
- Customer Diversification: Evaluate efforts to reduce reliance on a small number of customers for revenue generation.
- Lease Commitments: Review the impact of the new $3.0 million lease obligation on future cash flow requirements.